Understanding & Control of Material Process Variance in Generic Drug Manufacturer (Q233375): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in nl: translated_label)
(‎Created claim: summary (P836): Inzicht in & Controle van materiaalprocesvariantie in generieke drugfabrikant, translated_summary)
Property / summary
 
Inzicht in & Controle van materiaalprocesvariantie in generieke drugfabrikant (Dutch)
Property / summary: Inzicht in & Controle van materiaalprocesvariantie in generieke drugfabrikant (Dutch) / rank
 
Normal rank
Property / summary: Inzicht in & Controle van materiaalprocesvariantie in generieke drugfabrikant (Dutch) / qualifier
 
point in time: 27 November 2021
Timestamp+2021-11-27T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 11:02, 27 November 2021

Project Q233375 in Ireland
Language Label Description Also known as
English
Understanding & Control of Material Process Variance in Generic Drug Manufacturer
Project Q233375 in Ireland

    Statements

    0 references
    102,773.69 Euro
    0 references
    205,547.38 Euro
    0 references
    50.0 percent
    0 references
    1 March 2015
    0 references
    20 August 2017
    0 references
    University of Limerick
    0 references
    Understanding & Control of Material Process Variance in Generic Drug Manufacturer (English)
    0 references
    Comprendre & Contrôle de la variation du processus matériel chez le fabricant de médicaments génériques (French)
    25 November 2021
    0 references
    Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller (German)
    25 November 2021
    0 references
    Inzicht in & Controle van materiaalprocesvariantie in generieke drugfabrikant (Dutch)
    27 November 2021
    0 references

    Identifiers

    305
    0 references